TABLE OF CONTENTS

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No.  )
Filed by the Registrant ☑
Filed by a Party other than the Registrant  ☐
Check the appropriate box:
 ☐
Preliminary Proxy Statement
Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to § 240.14a-12
SANUWAVE Health, Inc.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
No fee required.
 ☐
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1)
Title of each class of securities to which transaction applies:
2)
Aggregate number of securities to which transaction applies:
3)
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
4)
Proposed maximum aggregate value of transaction:
5)
Total fee paid:
required
 ☐
Fee paid previously with preliminary materials.materials
 ☐
Check box if any part of the fee is offset as providedFee computed on table in exhibit required by Item 25(b) per Exchange Act Rule 0-11(a)(2)Rules 14a-6(i)(1) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
1)
Amount Previously Paid:
2)
Form, Schedule or Registration Statement No.:
3)
Filing Party:
4)
Date Filed:
0-11

TABLE OF CONTENTS


SANUWAVE Health, Inc.
3360 Martin Farm11495 Valley View Road Suite 100
Suwanee, GA 30024Eden Prairie, Minnesota 55344

NOTICE OF 2020 SPECIAL MEETING OF STOCKHOLDERS
CONSENT SOLICITATION
to be held on:
December 30, 2020
1:00 pm Eastern TimeNovember 18, 2022
Dear Stockholder:
YouThis Notice of Consent Solicitation (the “Notice”) and accompanying Consent Solicitation Statement are cordially invitedfurnished to attend a special meeting of stockholders (“Special Meeting”) ofyou by SANUWAVE Health, Inc., a Nevada corporation (“SNWV”we,” “us or the “Company”our), which will be held at 1:00 pm (Eastern Time) on December 30, 2020. The Special Meeting will bein connection with the solicitation of written consents from the holders of its common stock, par value $0.001 (the “Common Stock”), to take action without a virtual meeting of stockholders conducted online by live audio webcast. You will be able to attend the virtual meeting, vote your shares electronically and submit questions during the meeting by visiting www.virtualshareholdermeeting.com/SNWV2020SM at the date and time described in the accompanying proxy statement. There is no physical location for this Special Meeting.stockholders’ meeting.
We are holding the Special Meeting forsoliciting your written consent with respect to the following purpose, which isproposals (the “Proposals”):
Proposal 1 (Proposal 1): To approve an amendment to our Articles of Incorporation to effect a reverse stock split of our outstanding Common Stock at a reverse stock split ratio ranging from any whole number between 1-for-50 and 1-for-100, subject to and as determined by the Board of Directors (the “Board”).
Proposal 2 (Proposal 2): To approve an amendment to our Articles of Incorporation to increase the number of authorized shares of Common Stock from 800,000,000 to 2,500,000,000.
Our Board adopted Proposals 1 and 2 and recommends that stockholders give written consent FOR the approval of both Proposals.
The foregoing items of business are more fully described in the proxy statementConsent Solicitation Statement accompanying this notice:Notice.
1.
To approve an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of the Company’s common stock by 200 million shares to 800 million shares (“Proposal 1”);
2.
To grant the board of directors the authority to effect a reverse split of the Company’s outstanding common stock, par value $0.001 per share (the “Common Stock”), at an exchange rate of 1-for-50 (the “Proposal 2”); and
3.
To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
Only stockholders of record as ofWe have established the close of business on December 8, 2020 areOctober 28, 2022 (the “Record Date”) as the record date for determining stockholders entitled to notice and to vote atsubmit written consents. A majority of the Special Meeting or any postponement or adjournment thereof.
Important Notice Regarding the Availabilityshares of Proxy Materials for the
Stockholders’ Meeting to Be Held on
Wednesday, December 30, 2020 at 1:00 pm (Eastern Time) online at
www.virtualshareholdermeeting.com/SNWV2020SM.
The proxy statement and related materialsCommon Stock that are available at www.proxyvote.com
BY ORDER OF THE BOARD OF DIRECTORS
Kevin A. Richardson, II
Chief Executive Officer
Suwanee, Georgia
December 14, 2020

TABLE OF CONTENTS

YOUR VOTE IS IMPORTANT
You are cordially invited to attend the meeting online. Whether or not you expect to attend the meeting, please voteoutstanding on the mattersRecord Date must give written consent in favor for each of the Proposals to be considered as promptly as possible in orderapproved by stockholders.
This solicitation is being made on the terms and subject to ensure your representation at the meeting. You may vote via the Internet or by returning the enclosed proxy card. Even if you have voted by proxy, you may still vote if you attend the meeting online. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder. Your proxy is revocable in accordance with the proceduresconditions set forth in the proxy statement.accompanying Consent Solicitation Statement and the written consent card set forth in Appendix A. Written consents shall be solicited until the earliest of (i) the date we receive the affirmative consent to each of the Proposals of stockholders holding a majority of the shares of Common Stock as of the Record Date, (ii) the date the Board determines to terminate the solicitation and (iii) December 27, 2022 (the “Expiration Date”). If the requisite number of written consents for a Proposal is received on or prior to the Expiration Date, such Proposal will be deemed approved on the Expiration Date.
Failure to submit the written consent will have the same effect as a written consent against each of the Proposals. We recommend that all stockholders affirmatively consent to the Proposals, by marking the box entitled “FOR” with respect to Proposal 1 and Proposal 2. If you sign and send in the written consent card but do not indicate how you want to vote as to either Proposal, your written consent card will be treated as a consent “FOR” that Proposal.
By Order of the Board of SANUWAVE Health, Inc.
/s/ Kevin A. Richardson, II
Kevin A. Richardson, II
Chief Executive Officer
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIAL
FOR THE WRITTEN CONSENT SOLICITATION
The Notice of Consent Solicitation and Consent Solicitation Statement are available at www.proxyvote.com.

TABLE OF CONTENTS

SANUWAVE Health, Inc.

11495 Valley View Road

TABLE OF CONTENTS

Eden Prairie, Minnesota 55344
(770) 419-7525

PROXYCONSENT SOLICITATION STATEMENT
FOR THE 2020 SPECIAL MEETING OF STOCKHOLDERS
December 30, 2020
QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING
WhyThis Consent Solicitation Statement and accompanying Notice of Consent Solicitation (“Notice”) are these proxy materials being made available?furnished to you by SANUWAVE Health, Inc., a Nevada corporation (“we,” “us,” “our” or the “Company”), in connection with the solicitation of written consents from the holders of its common stock, par value $0.001 (the “Common Stock”), to take action without a stockholders’ meeting.
On or about December 14, 2020,November 18, 2022, we willintend to mail to our stockholders of record and beneficial owners a 2020 Special Notice, (“Notice”)this Consent Solicitation Statement and Proxythe written consent card set forth in Appendix A (collectively, the “consent solicitation materials”).
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIAL
FOR THE WRITTEN CONSENT SOLICITATION
The Notice of Consent Solicitation and Consent Solicitation Statement (the proxy materials).are available at www.proxyvote.com.
QUESTIONS AND ANSWERS ABOUT THESE CONSENT SOLICITATION MATERIALS
Why are these consent solicitation materials being made available?
We are providing you with these proxyconsent solicitation materials because the boardour Board of directors of SANUWAVE Health, Inc. (which we refer to in this proxy statement as “we,Directors (the “Board “us,” “our,” “SNWV” and the “Company”) is soliciting written consents from the holders of our Common Stock to take action without a stockholders’ meeting.
We are soliciting your proxywritten consent with respect to votethe following proposals (the “Proposals”):
Proposal 1 (Proposal 1): To approve an amendment to our Articles of Incorporation to effect a reverse stock split of our outstanding Common Stock at a reverse stock split ratio ranging from any whole number between 1-for-50 and 1-for-100, subject to and as determined by the 2020 Special MeetingBoard.
Proposal 2 (Proposal 2): To approve an amendment to our Articles of StockholdersIncorporation to increase the number of authorized shares of Common Stock from 800,000,000 to 2,500,000,000.
This solicitation is being made on the terms and subject to the conditions set forth in this Consent Solicitation Statement and the accompanying written consent card. Written consents shall be solicited until the earliest of (i) the date we receive the affirmative consent to each of the Proposals of stockholders holding a majority of the shares of Common Stock as of the Record Date, (ii) the date the Board determines to terminate the solicitation and (iii) December 27, 2022 (the “Special Meeting”Expiration Date), and any adjournments. If the requisite number of written consents for a Proposal is received on or postponement thereof,prior to be held via a live audio webcast on December 30, 2020, at 1:00 pm (Eastern Time). You are invited to virtually attend the special meeting by visiting www.virtualshareholdermeeting.com/SNWV2020SM where youExpiration Date, such Proposal will be able to listen todeemed approved on the meeting live, submit questions and vote online. However, you do not need to virtually attend the meeting to vote your shares. Instead, you may simply vote your shares by proxy via the Internet or by completing, signing and returning the enclosed proxy card.Expiration Date.
What is the purpose of the Special Meeting?
At our Special Meeting, stockholders will vote upon the following two matters scheduled for a vote:
1.
To approve an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of the Company’s common stock by 200 million shares to 800 million shares (“Proposal 1”); and
2.
To grant the Board the authority to effect a reverse split of the Company’s outstanding common stock, par value $0.001 per share (the “Common Stock”), at an exchange rate of 1-for-50 (“Proposal 2”).
Could other matters be properly brought before the Special Meeting?
The Board knows of no other matters that will be presented for consideration at the Special Meeting. If any other matter is properly brought before the Special Meeting, the proxy holders appointed by our Board will have the discretion to vote on those matters for you in accordance with their best judgment.
What proxyconsent solicitation materials are available on the Internet?
The 2020 Special Meeting ProxyNotice, this Consent Solicitation Statement isand the written consent card set forth in Appendix A are available at www.proxyvote.com
How do I attend the Special Meeting?
The 2020 Special Meeting will be held entirely online via audio webcast to allow greater participation. You may attend, vote and ask questions at the Special Meeting by following the instructions provided on the Notice to log in to www.virtualshareholdermeeting.com/SNWV2020SM. If you are a stockholder of record, you will be asked to provide the control number from your Notice. If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, follow the instructions from your broker or bank.www.proxyvote.com.
Who can vote atsubmit a written consent with respect to the Special Meeting?Proposals?
Stockholders as of the record date for the Special Meeting, December 8, 2020,close of business on October 28, 2022 (the “Record Date”) are entitled to vote atsubmit a written consent with respect to the Special Meeting. OnProposals. For each matter to be voted on,Proposal, you have one vote for each share of common stockCommon Stock you own as of the record date.Record Date. At the close of business on the record date,Record Date, there were 467,194,621548,737,651 shares of the Company’s common stockCommon Stock outstanding and entitled to vote.
How do I submit my written consent?
Your written consent is important. We urge you to submit your written consent over the Internet, by telephone or by completing and returning the written consent card set forth in Appendix A.
1

TABLE OF CONTENTS

How do I vote?
Your vote is important. Whether or not you plan to attend the Special Meeting, we urge you to vote over the Internet, by telephone or by proxy to ensure that your vote is counted. You may still attend the Special Meeting if you have already voted by proxy.
Stockholder of Record: Shares Registered in Your Name
If, on December 8, 2020,the Record Date, your shares were registered directly in your name with our transfer agent, Action Stock Transfer, then you are considered the stockholder of record with respect to those shares.
As a stockholder of record, you may vote at the Special Meeting or vote by proxy. Whether or not you plan to attend the Special Meeting, wesubmit your written consent directly. We urge you to votesubmit your written consent over the Internet, or by telephone or if you request paper proxy materials, by filling outcompleting and returning the proxy card.written consent card set forth in Appendix A.
If you are a stockholder of record, you may:
vote by proxy-to vote using the printed proxy card that may be delivered to you, simply complete, sign and date the proxywritten consent card and return it promptly in the envelope provided. If you return your signed proxy card to us before the Special Meeting, we will vote your shares as you instruct;provided;
vote by Internet-gogo to www.proxyvote.com to complete an electronic proxywritten consent card. You will be asked to provide the control number from your Notice. Your vote must be received by 11:59 p.m. Eastern Time on December 29, 2020 to be counted;Notice; or
vote via telephone-dialdial toll-free 1-800-690-6903 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the control number from the Notice. Your vote must be received by 11:59 p.m. Eastern Time on December 29, 2020 to be counted.
To determine how you may revoke or change your votewritten consent submitted by the telephone, Internet or mail methods described above, see the section entitled “How can I change my vote after submitting my proxy?written consent?
Beneficial Owner: Shares Registered in the Name of a Broker or Nominee
If, on December 8, 2020,the Record Date, your shares were held in an account at a brokerage firm, bank, dealer, or other similar organization, then you are the beneficial owner of shares held in “street name” and the Notice is being forwarded to you by that organization. The organization holding your account is considered the stockholder of record for purposes of voting at the special meeting.this consent solicitation. As a beneficial owner, you have the right to direct your broker or other agent on how to votecomplete the written consent with respect to the shares in your account. You are also invited to attend the special meeting. However, since you are not the stockholder of record, you may not vote your shares via live webcast at the meeting unless you request and obtain a valid proxy from your broker or other agent.
What is the recommendation of the Board on each of the proposals scheduled to be voted on at the Special Meeting?Proposals?
The Board recommends that you vote:submit your written consent:
FOR the approval of an amendment to amendour Articles of Incorporation to effect a reverse stock split of our outstanding Common Stock at a reverse stock split ratio ranging from any whole number between 1-for-50 and 1-for-100, subject to and as determined by the Company’sBoard (Proposal 1); and
FOR the approval of an amendment to our Articles of Incorporation to increase the number of authorized shares of the Company’s common stock (Proposal 1); and
FOR the grant of authorityCommon Stock from 800,000,000 to the Board to effect a reverse split of the Company’s outstanding common stock2,500,000,000 (Proposal 2).
What if I return my proxywritten consent card directly to the Company, but do not provide voting instructions?instructions with respect to either of the Proposals?
If a signed proxywritten consent card is returned to us without any indication of how your shares should be voted on a particular proposal at the meeting,Proposal, your shareswritten consent card will be voted in accordance with the recommendations of the Board, stated above. For example, if you returntreated as a signed proxy card with no indication of your vote on any of the proposals, your votes will be castconsent “FOR” the approval to amend the Company’s Articles of Incorporation to increase the number of authorized shares of the Company’s common stock in Proposal 1, and “FOR” the grant of authority to the Board to effect a reverse split of the Company’s outstanding common stock in Proposal 2. If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment.
2

TABLE OF CONTENTS

If you hold your shares in street name and do not vote, and your broker does not have discretionary power to vote your shares, your shares may constitute “broker non-votes” (as described below) and may not be counted in determining the number of shares necessary for approval of a proposal. However, shares that constitute broker non-votes will be counted for the purpose of establishing a quorum for the Special Meeting. Voting results will be tabulated and certified by the inspector of elections appointed for the meeting.each Proposal.
How can I change my vote after submitting my proxy?written consent?
A stockholder who has given a proxywritten consent may revoke it at any time before it is exercised at the meetingExpiration Date by:
delivering to the Corporate Secretary of the Company a written notice stating that the proxywritten consent is revoked;
signing and delivering a proxywritten consent card bearing a later date;
voting againcompleting a new electronic written consent card over the Internet or by telephone;Internet; or
attending the Special Meeting and voting online (although attendance at the meeting will not,submitting new instructions by itself, revoke a proxy).telephone.
Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to revoke a proxy,written consent, you must contact that firm to revoke any prior voting instructions.written consent.
What is the quorum requirement for the Special Meeting?
2
A majority of our outstanding shares as of the record date must be present at the meeting in order to hold the meeting and conduct business. This presence is called a quorum. Your shares are counted as present at the meeting if you are present and vote in person at the meeting or if you have properly submitted a proxy.

What is the vote required for each proposal?Proposal?
The votes required to approve each proposalProposal are as follows:
Proposal 1. The amendment to our Articles of Incorporation to increaseeffect a reverse stock split of our outstanding Common Stock at a reverse stock split ratio ranging from any whole number between 1-for-50 and 1-for-100, subject to and as determined by the number of authorized shares of the Company’s common stockBoard requires the affirmative voteconsent of the holders of a majority of the outstanding shares of common stockCommon Stock for approval. Abstentions and any broker non-votes will have the same effect as a votewritten consent “against” Proposal 1.
Proposal 2. The grantamendment to our Articles of authorityIncorporation to increase the Boardnumber of authorized shares of Common Stock from 800,000,000 to effect a reverse split of the Company’s outstanding common stock2,500,000,000 requires the affirmative voteconsent of the holders of a majority of the outstanding shares of common stockCommon Stock for approval. Abstentions and any broker non-votes will have the same effect as a votewritten consent “against” Proposal 2.
What are “broker non-votes”?
Broker non-votes occur when shares held by a broker for a beneficial owner are not voted because (i) the broker did not receive voting instructions from the beneficial owner, and (ii) the broker lacked discretionary authority to votesubmit a written consent with respect to the shares. These unvoted shares are considered “broker non-votes” with respect to such matters. Broker non-votes
The Proposals are counted for purposes of determining whether a quorum is present. Note that ifconsidered “routine” proposals under New York Stock Exchange rules. If you are a beneficial holderowner and your shares are held in the name of a broker or other nominee, the broker or other nominee is permitted to submit your written consent on the Proposals, even if the broker or other nominee does not receive instructions from you. As a result, we do not provide specific voting instructions to youranticipate any broker the broker that holds your shares will not be authorized to vote on the approval to amend the Company’s Articles of Incorporation to increase the number of authorized shares of the Company’s common stock (Proposal 1), or to vote on the grant for authoritynon-votes with respect to the Board to effect a reverse split of the Company’s outstanding common stock (Proposal 2).Proposals.
Who is paying for this proxywritten consent solicitation?
The Company is paying the costs of the solicitation of proxies. Proxieswritten consents. Written consents may be solicited on behalf of the Company by our directors, officers, employees or agents in person or by telephone, facsimile or other electronic means. We will also reimburse brokerage firms and other custodians, nominees and fiduciaries, upon request, for their reasonable expenses incurred in sending proxieswritten consents and proxyconsent solicitation materials to beneficial owners of our common stock. We have retained the services of Okapi Partners LLC to assist in the solicitation of proxies for a fee of approximately $8,500 plus reasonable out-of-pocket expenses. We may engage Okapi Partners LLC for additional solicitation work and incur fees greater than $8,500 depending on a variety of factors, including preliminary voting results.Common Stock.
3

TABLE OF CONTENTS

What does it mean if I receive more than one proxywritten consent card?
If you receive more than one proxywritten consent card, your shares are registered in more than one name or are registered in different accounts. Please complete, sign and return each proxywritten consent card to ensure that all of your shares are voted.
Where can I find the voting results?
The final results will be tallied by the inspector of elections and filed with the Securities and Exchange Commission (the “SEC”) in a current reportCurrent Report on Form 8-K within four business days of the Special Meeting.Expiration Date.
43

TABLE OF CONTENTS

PROPOSAL 1
APPROVAL OF AN AMENDMENT TO THE COMPANY’S ARTICLES OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK BY TWO HUNDRED MILLION SHARES TO EIGHT HUNDRED MILION SHARES OF COMMON STOCK
The Board has approved an amendment to our Articles of Incorporation to increase the number of authorized shares of common stock to 800 million shares from 600 million shares. If approved, the amendment would delete the text of the third paragraph thereof referring to the number of shares with par value in its entirety and by adding, in lieu thereof, the following text:
“The total number of shares which the Corporation is authorized to issue is 805,000,000 shares. 800,000,000 shares shall be Common Stock, each having a par value of $0.001. 5,000,000 shares shall be Preferred Stock, each having a par value of $0.001.”
If the above amendment is approved, the full text of the Articles of Incorporation will be as set forth in Appendix A-1 attached hereto.
On December 8, 2020, the record date, we had 467,194,621 shares of common stock issued and outstanding and 132,805,379 shares of common stock that were authorized but unissued. On December 8, 2020, we had reserved 252,403,169 shares for future issuance, consisting of (i) 157,106,736 shares of common stock potentially issuable upon exercise of outstanding warrants, (ii) 32,618,385 shares of Common Stock potentially issuable upon exercise of outstanding stock options and (iii) 62,678,048 shares of Common Stock potentially issuable upon the conversion of outstanding convertible notes. Accordingly, we need to increase our authorized shares of common stock in order to effect the conversion of all such convertible securities.
The Board believes that the availability of additional authorized shares of common stock will provide the Company with additional flexibility to issue common stock for a variety of general corporate purposes as the Board may determine to be desirable including, without limitation, stock splits (including splits effected through the declaration of stock dividends), raising capital, future financings, investment opportunities, licensing agreements, acquisitions or other distributions. The Company currently does not have any definitive plans, arrangements, understandings or commitments with respect to the issuance of the additional shares of common stock authorized by the proposed amendment to the Articles of Incorporation, other than to allow the conversion of currently outstanding convertible securities as described above.
The proposed amendment to increase the authorized number of shares of common stock could, under certain circumstances, have an anti-takeover effect or delay or prevent a change in control of the Company by providing the Company the capability to engage in actions that would be dilutive to a potential acquiror, to pursue alternative transactions, or to otherwise increase the potential cost to acquire control of the Company. Thus, while the Company currently has no intent to employ the additional unissued authorized shares as an anti-takeover device, the proposed amendment may have the effect of discouraging future unsolicited takeover attempts. The Board is not aware of any such attempt to take control of the Company, and would act in the best interest of stockholders if any attempt was made. The proposed amendment has been prompted by business and financial considerations.
The proposed increase in the number of authorized shares of the Company's common stock will not change the number of shares of common stock outstanding, nor will it have any immediate dilutive effect or change the rights of current holders of the Company's common stock. However, the issuance of additional shares of common stock authorized by this amendment to the Articles of Incorporation may occur at times or under circumstances as to have a dilutive effect on earnings per share, book value per share or the percentage voting or ownership interest of the present holders of the Company's common stock.
Once the proposed amendment is approved, no further action by the stockholders would be necessary prior to the issuance of additional shares of common stock unless required by law or the rules of any stock exchange or national securities association on which the common stock is then listed or quoted. Under the proposed amendment, each of the newly authorized shares of common stock will have the same rights and privileges as currently authorized common stock. Adoption of the proposed amendment will not affect the rights of the holders of currently outstanding common stock of the Company nor will it change the par value of the common stock, which will remain $0.001 par value per share. If the proposed amendment is adopted, it will become effective upon filing of an amendment to the Company’s Articles of Incorporation with the Nevada Secretary of State.
5

TABLE OF CONTENTS

Required Vote
The affirmative vote of the holders of a majority of the shares of common stock outstanding is needed to approve the amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of common stock by 200 million to 800 million shares of common stock.
THE BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” PROPOSAL 1, THE AMENDMENT OF THE COMPANY’S ARTICLES OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF THE COMPANY’S COMMON STOCK BY 200 MILLION TO 800 MILLION.
6

TABLE OF CONTENTS

PROPOSAL 2
AUTHORIZING THE BOARD OF DIRECTORS TO AMEND THE COMPANY'S ARTICLES OF INCORPORATION TO EFFECT THE REVERSE STOCK SPLIT PROPOSAL
Our Board has adopted resolutions to authorize the Board, in its sole discretion, to (1) amend the Company’sour Articles of Incorporation to effect a reverse stock split of our issued and outstanding common stock (the “ReverseCommon Stock Split”) and (2) directingdirect such proposal to be submitted to the holders of our voting capitalCommon Stock for their approval. The amendment to our Articles of Incorporation would be accomplished by adding to the end of the third paragraph thereof referring to the number of shares with par value the following text:
Upon the filing and effectiveness (the “Reverse Stock Split Effective asTime”) pursuant to the General Corporation Law of 12:01 a.m. Eastern time, onNevada of the date immediately following the date this Certificate of Amendment of Amended and Restated Certificateto these Articles of Incorporation is filed with the Secretary of State of the State of Nevada,Corporation, each fifty (50)[•] shares of the Corporation’s Common Stock issued and outstanding immediately prior to the Reverse Stock Split Effective Time shall, automatically and without any further action on the part of the Corporation or any of the respective holders thereof, be reclassified, combined and converted into one (1) fully paid and nonassessable share of Common Stock (the “Reverse Stock Split”); provided, however, that, subject to the Corporation shall issue notreatment of fractional sharesshare interests as a resultdescribed below. The reclassification of the Common Stock will be deemed to occur at the Reverse Stock Split butEffective Time. From and after the Reverse Stock Split Effective Time, certificates representing Common Stock prior to such reclassification shall instead roundrepresent the number of shares of Common Stock into which such Common Stock prior to such reclassification shall have been reclassified pursuant to the Certificate of Amendment. No fractional shares shall be issued in connection with the Reverse Stock Split and, in lieu thereof, the number of shares to be received by a stockholder shall be rounded up to the nextnearest whole number.number of shares in the event that such stockholder would otherwise be entitled to receive a fractional share upon the Reverse Stock Split.
If approved by the holders of our voting capital,Common Stock, the Reverse Stock Split proposal would permit, but not require, our Board to effect a reverse stock split of our issued and outstanding common stockCommon Stock at any time prior to December 31, 20212023 at a reverse stock split ratio ranging from any whole number between 1-for-50 and 1-for-100, subject to and as determined by a ratio of 1-for-50. We believe that enabling ourthe Board to implement the (the “Reverse Stock Split will provide us with the flexibility to implement the Reverse Stock Split in a manner designed to maximize the anticipated benefits for our stockholders.
”). Our Board reserves the right to elect to abandon the Reverse Stock Split, if it determines, in its sole discretion, that the Reverse Stock Split is no longer in the best interests of the Company and its stockholders.
50 shares of existing common stock will be combined into one share of common stock. AnyWe do not intend to issue fractional shares in connection with the Reverse Stock Split. In lieu of issuing fractional shares, we will be roundedround up to the next whole number.number of shares.
Background and Reasons for the Reverse Stock Split; Potential Consequences of the Reverse Stock Split
Our Board is submitting the Reverse Stock Split to our stockholders for approval with the primary intent of (1) avoiding an event of default under the future advance convertible promissory notes (the “Notes”) we issued in a private placement that closed on August 5, 2022 and (2) increasing the market price of our common stock which may enhance liquidityCommon Stock to satisfy one of the initial listing requirements for uplisting onto The Nasdaq Capital Market, although we are under no obligation to uplist and there can be no assurance that the trading price of our Common Stock would be maintained at such level or that we will be able to makemaintain any such listing of our common stock more attractiveCommon Stock on The Nasdaq Capital Market if we are able to a broader range of investors. Accordingly, for these and other reasons discussed below, we believe that effecting the Reverse Stock Split isuplist in the Company’sfuture.
On August 5, 2022, we entered into a Securities Purchase Agreement for the sale in a private placement of (i) the Notes in an aggregate principal amount of approximately $16.1 million, (ii) warrants to purchase an additional 403 million shares of Common Stock with an exercise price of $0.067 per share (the “First Warrants”) and (iii) warrants to purchase an additional 403 million shares of Common Stock with an exercise price of $0.04 per share (the “Second Warrants,” collectively with the First Warrants, the “Warrants”). The Notes and the Warrants are not currently convertible into, or exercisable for, shares of our stockholders’ best interests. WeCommon Stock. The Notes will be convertible and the Warrants exercisable at such time as our authorized and unissued shares of Common Stock are at a number sufficient to permit the exercise or conversion of all outstanding securities exercisable for, or convertible into, Common Stock.
Pursuant to each Note, failure to reduce our outstanding shares via a reverse stock split to provide a number of authorized and unissued shares of Common Stock sufficient to permit the conversion of the Note and the conversion or exercise, as applicable, of all other outstanding securities of the Company convertible into or exercisable for shares of Common Stock on or before December 31, 2022 is an event of default. Upon an event of default under the Notes, we will have five business days after notice of default from a holder to cure the event of default. After such cure period, the holder may require the Company, by delivering written notice, to redeem all or any part of its Note in cash at a price equal to (1) principal plus accrued and unpaid interest, calculated from the event of default at an interest
4

rate of 20% per annum (the “Event of Default Redemption Price”) and (2) liquidated damages of $250,000 pro-rata based on the entire amount raised in the private placement plus an amount in cash equal to 1% of the Event of Default Redemption Price for each 30-day period during which redemptions fail to be made, with a cap at 5%.
In addition, we believe that the Reverse Stock Split, if implemented, will make our voting common stockCommon Stock more attractive to a broader range of institutional and other investors, as we believe that the current market price of our voting common stockCommon Stock may affect its acceptability to certain institutional investors, professional investors and other members of the investing public. Many brokerage houses and institutional investors have internal policies and practices that either prohibit them from investing in low-priced stocks or tend to discourage individual brokers from recommending low-priced stocks to their customers. In addition, some of those policies and practices may function to make the processing of trades in low-priced stocks economically unattractive to brokers. Moreover, because brokers’ commissions on low-priced stocks generally represent a higher percentage of the stock price than commissions on higher-priced stocks, the current average price per share of voting common stockCommon Stock can result in individual stockholders paying transaction costs representing a higher percentage of their total share value than would be the case if the share price were substantially higher. We believe that, if approved and implemented by our Board, the Reverse Stock Split will make our voting common stockCommon Stock a more attractive and cost effectivecost-effective investment for many investors, which will enhance the liquidity of the holders of our voting common stock.investors.
Reducing the number of outstanding shares of our common stockCommon Stock through the Reverse Stock Split is intended, absent other factors, to increase the per share market price of our common stock.Common Stock. However, other factors, such as our financial results, market conditions and the market perception of our business may adversely affect the market price of our common stock.Common Stock. As a result, there can be no assurance that the Reverse Stock Split, if completed, will result in the intended benefits described above, that the market price of our common stockCommon Stock will increase following the Reverse Stock Split or that the market price of our common stockCommon Stock will not decrease in the future. Additionally, we cannot assure you that the market price per share of our common stockCommon Stock after a Reverse Stock Split will increase in
7

TABLE OF CONTENTS

proportion to the reduction in the number of shares of our common stockCommon Stock outstanding before the Reverse Stock Split. Accordingly, the total market capitalization of our common stockCommon Stock after the Reverse Stock Split may be lower than the total market capitalization before the Reverse Stock Split.
Criteria the Board of Directors May Use to Determine Whether to Implement the Reverse Stock Split
When determining whether to implement the Reverse Stock Split, and which Reverse Stock Split ratio to implement, if any, following the receipt of stockholder approval, the Board of Directors may consider various factors, including:
the financial consequences to the Company of triggering an event of default under the Notes;
the initial listing requirements for uplisting onto The Nasdaq Capital Market;
the historical trading price and trading volume of our Common Stock;
the then-prevailing trading price and trading volume of our Common Stock and the expected impact of the Reverse Stock Split on the trading market for our Common Stock in the short- and long-term;
the number of shares of our Common Stock outstanding;
the anticipated impact of a particular ratio on the Company’s ability to reduce administrative and transactional costs; and
prevailing general market, legal and economic conditions.
Prior Approval of a Reverse Stock Split
At the 2020 Annual Meeting of Stockholders of the Company, held on July 23, 2020, the stockholders authorized the Board to amend the Company’sour Articles of Incorporation to effect a reverse stock split by approving Proposal 5 as set forth in the Proxy Statement for the 2020 Annual Meeting of Stockholders filed with the SEC on June 26, 2020 (“Proposal 5”).2020. The authorization permitted, but did not require, the Board to effect the reverse stock split at any time prior to August 22, 2020. The Board, pursuant to the terms of the approvals and authorizations set forth in Proposal 5, did not elect to effect the reverse stock split prior to August 22, 2020.
At the 2020 Special Meeting of Stockholders held on December 30, 2020, the stockholders authorized the Board to amend our Articles of Incorporation to effect a reverse stock split by approving Proposal 2 as set forth in the Proxy Statement for the 2020 Special Meeting of Stockholders filed with the SEC on December 14, 2020. The authorization permitted, but did not require, the Board to effect the reverse stock split prior to December 31, 2021. The Board,
5

pursuant to the terms of the approvals and authorizations set forth in Proposal 2, did not elect to effect the reverse stock split prior to December 31, 2021. The Board is therefore seeking stockholder approval for the Reverse Stock Split.
Procedure for Implementing the Reverse Stock Split
The Reverse Stock Split, if approved by our stockholders, would become effective uponon the filing (the “Effective Time”)date and time set forth in the Certificate of a certificate of amendmentAmendment to our Articles of Incorporation that is filed with the Nevada Secretary of State, which we expect would be shortly after such filing is made with the Nevada Secretary of the State of Nevada.(the “Effective Time”). The exact timing of the filing of the certificateCertificate of amendmentAmendment that will effect the Reverse Stock Split will be determined by our Board based on its evaluation as to when such action will be the most advantageous to the Company and our stockholders. In addition, our Board reserves the right, notwithstanding stockholder approval and without further action by the stockholders, to elect not to proceed with the Reverse Stock Split if, at any time prior to filing the amendment to the Company’sour Articles of Incorporation, our Board, in its sole discretion, determines that it is no longer in our best interest and the best interests of our stockholders to proceed with the Reverse Stock Split. If a certificateCertificate of amendmentAmendment effecting the Reverse Stock Split has not been filed with the Nevada Secretary of State of the State of Nevada by the close of business on December 31, 2021,2023, our Board will abandon the Reverse Stock Split.
Effect of the Reverse Stock Split on Holders of Outstanding Common Stock
Based on 467,194,621 shares of common stock outstanding as of the Record Date, the Reverse Stock Split would result in (without giving effect to the treatment of fractional shares) 9,343,893 outstanding shares of common stock (excluding Treasury shares).
The Reverse Stock Split will affect all holders of our common stock uniformly and will not affect any stockholder’s percentage ownership interest in the Company, except that as described below in “Fractional Shares,” record holders of common stock otherwise entitled to a fractional share as a result of the Reverse Stock Split will be rounded up to the next whole number. In addition, the Reverse Stock Split will not affect any stockholder’s proportionate voting power (subject to the treatment of fractional shares).
The implementation of the Reverse Stock Split will result in an increased number of available authorized shares of Common Stock because the authorized number of shares of Common Stock will not be correspondingly reduced as a result of the Reverse Stock Split. In particular, the number of authorized shares of Common Stock immediately prior to the Reverse Stock Split will be the same as the number of authorized shares of Common Stock immediately after the Reverse Stock Split. The resulting increase in such availability in the authorized number of shares of Common Stock could have a number of effects on the Company’s stockholders depending upon the exact nature and circumstances of any actual issuances of authorized but unissued shares. The increase in available authorized shares for issuance could have an anti-takeover effect, in that additional shares could be issued (within the limits imposed by applicable law) in one or more transactions that could make a change in control or takeover of the Company more difficult. For example, additional Common Stock could be issued by the Company so as to dilute the stock ownership or voting rights of persons seeking to obtain control of the Company, even if the persons seeking to obtain control of the Company offer an above-market premium that is favored by a majority of the independent stockholders. Similarly, the issuance of additional Common Stock to certain persons allied with the Company’s management could have the effect of making it more difficult to remove the Company’s current management by diluting the stock ownership or voting rights of persons seeking to cause such removal. The Company does not have any other provisions in its Articles of Incorporation, bylaws, employment agreements, credit agreements or any other documents that have material anti-takeover consequences. Additionally, the Company has no plans or proposals to adopt other provisions or enter into other arrangements that may have material anti-takeover consequences. The Board is not aware of any attempt, or contemplated attempt, to acquire control of the Company, and this proposal is not being presented with the intent that it be utilized as a type of anti-takeover device.
8

TABLE OF CONTENTS

Additionally, because holders of Common Stock have no preemptive rights to purchase or subscribe for any unissued stock of the Company, the issuance of additional shares of authorized Common Stock that will become newly available as a result of the implementation of the Reverse Stock Split will reduce the current stockholders’ percentage ownership interest in the total outstanding shares of Common Stock.
The Company may issue the additional shares of authorized Common Stock that will become available as a result of the Reverse Stock Split without the additional approval of its stockholders. The Company currently does not have any definitive plans, arrangements, understandings or commitments with respect to the issuance of the additional shares of authorized Common Stock that will become available as a result of the Reverse Stock Split, other than to allow the conversion of currently outstanding convertible securities as described above.
The Reverse Stock Split may result in some stockholders owning “odd lots” of less than 100 shares of common stock. Odd lot shares may be more difficult to sell, and brokerage commissions and other costs of transactions in odd lots are generally somewhat higher than the costs of transactions in “round lots” of even multiples of 100 shares.
After the Effective Time, our common stock will have new Committee on Uniform Securities Identification Procedures (“CUSIP”) numbers, which is a number used to identify our equity securities, and stock certificates with the older CUSIP numbers will need to be exchanged for stock certificates with the new CUSIP numbers by following the procedures described below. After the Reverse Stock Split, we will continue to be subject to the periodic reporting and other requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Our common stock will continue to be listed on the OTCQB under the symbol “SNWV,” subject to any decision of our Board to list our securities on another stock quotation service or a stock exchange.
Beneficial Holders of Common Stock (i.e., stockholders who hold in street name)
Upon the implementation of the Reverse Stock Split, we intend to treat shares held by stockholders through a bank, broker, custodian or other nominee in the same manner as registered stockholders whose shares are registered in their names. Banks, brokers, custodians or other nominees will be instructed to effect the Reverse Stock Split for their beneficial holders holding our common stock in street name. However, these banks, brokers, custodians or other nominees may have different procedures than registered stockholders for processing the Reverse Stock Split. Stockholders who hold shares of our common stock with a bank, broker, custodian or other nominee and who have any questions in this regard are encouraged to contact their banks, brokers, custodians or other nominees.
Registered “Book-Entry” Holders of Common Stock (i.e., stockholders that are registered on the transfer agent's books and records but do not hold stock certificates)
Certain of our registered holders of common stock may hold some or all of their shares electronically in book-entry form with the transfer agent. These stockholders do not have stock certificates evidencing their ownership of the common stock. They are, however, provided with a statement reflecting the number of shares registered in their accounts.
Stockholders who hold shares electronically in book-entry form with the transfer agent will not need to take action (the exchange will be automatic) to receive whole shares of post-Reverse Stock Split common stock, subject to adjustment for treatment of fractional shares.
Holders of Certificated Shares of Common Stock
Stockholders holding shares of our common stock in certificated form will be sent a transmittal letter by our transfer agent after the Effective Time. The letter of transmittal will contain instructions on how a stockholder should surrender his, her or its certificate(s) representing shares of our common stock (the “Old Certificates”) to the transfer agent in exchange for certificates representing the appropriate number of whole shares of post-Reverse Stock Split Common Stock (the “New Certificates”). No New Certificates will be issued to a stockholder until such stockholder has surrendered all Old Certificates, together with a properly completed and executed letter of transmittal, to the transfer agent. No stockholder will be required to pay a transfer or other fee to exchange his, her or its Old Certificates. Stockholders will then receive a New Certificate(s) representing the number of whole shares of common stock that they are entitled as a result of the Reverse Stock Split, subject to the treatment of fractional shares described below. Until surrendered, we will deem outstanding Old Certificates held by stockholders to be cancelled and only to represent the number of whole shares of post-Reverse Stock Split common stock to which these stockholders are entitled, subject to the treatment of fractional shares. Any Old Certificates submitted for exchange, whether because
9

TABLE OF CONTENTS

of a sale, transfer or other disposition of stock, will automatically be exchanged for New Certificates. If an Old Certificate has a restrictive legend on the back of the Old Certificate(s), the New Certificate will be issued with the same restrictive legends that are on the back of the Old Certificate(s).
THE COMPANY MAY ISSUE THE ADDITIONAL SHARES OF AUTHORIZED COMMON STOCK THAT WILL BECOME AVAILABLE AS A RESULT OF THE REVERSE STOCK SPLIT WITHOUT THE ADDITIONAL APPROVAL OF ITS STOCKHOLDERS.
Fractional Shares
We do not currently intend to issue fractional shares in connection with the Reverse Stock Split. Therefore, we will not issue certificates representing fractional shares. In lieu of issuing fractions offractional shares, we will round up to the next whole number.number of shares.
Effect of the Reverse Stock Split on Employee Plans, Options, RestrictedHolders of Outstanding Common Stock Awards
General
After the Effective Time of the Reverse Stock Split, should the Board elect to implement it, each stockholder will own a reduced number of shares of Common Stock. However, the Reverse Stock Split would affect all of our stockholders uniformly and Units, Warrants,would not affect any stockholder’s percentage ownership interests in the Company, except to the extent that the Reverse Stock Split results in any of our stockholders owning a fractional share as described above. Voting rights and Convertibleother rights and preferences of the holders of our Common Stock would not be affected by the Reverse Stock Split (other than as a result of the payment of cash in lieu of fractional shares). For example, a holder of 2% of the voting power of the outstanding shares of our Common Stock immediately prior to the Reverse Stock Split would continue to hold 2% (assuming there is no impact as a result of rounding up to the nearest whole share in lieu of issuing fractional shares) of the voting power of the outstanding shares of our Common Stock immediately after the Reverse Stock Split. The number of stockholders of record would not be affected by the Reverse Stock Split.
The principal effects of the Reverse Stock Split would be that:
each 50 to 100 shares of our Common Stock owned by a stockholder (depending on the Reverse Stock Split ratio selected by the Board), would be combined into one new share of our Common Stock;
no fractional shares of Common Stock would be issued in connection with the Reverse Stock Split, instead, any fractional shares will be rounded up to the next whole number of shares as explained above;
by reducing the number of shares of Common Stock outstanding without reducing the number of shares of available but unissued Common Stock, the Reverse Stock Split will effectively increase the relative number of authorized but unissued shares, which the Board may use in connection with future financings or Exchangeable Securitiesother issuances;
Proportionatebased upon the Reverse Stock Split ratio selected by the Board of Directors, proportionate adjustments are generally required towould be made to the per share exercise or conversion price and the number of shares issuable upon the exercise, conversion or conversionvesting of all then outstanding options,equity awards, Common Stock warrants and convertible or exchangeable securities entitlingdebt with respect to the holders to purchase, exchange for, or convert into, shares of common stock. This would result in approximately the same aggregate price being required to be paid under such options, warrants, convertible or exchangeable securities upon exercise, and approximately the same valuenumber of shares of common stock being delivered uponCommon Stock subject to such award, warrant or convertible debt and the exercise exchange or conversion immediatelyprice thereof, in each case to the extent applicable, subject to the terms of such awards, warrants or convertible debt;
6

the number of shares of Common Stock authorized under the Amended and Restated 2006 Stock Incentive Plan of SANUWAVE Health, Inc. (the “Stock Incentive Plan”) will be proportionately adjusted for the Reverse Stock Split ratio selected by the Board; and
the number of stockholders owning “odd lots” of less than 100 shares of our Common Stock may potentially increase; odd lot shares may be more difficult to sell and brokerage commissions and other costs of transactions in odd lots generally are proportionately higher than the costs of transactions in “round lots” of even multiples of 100 shares.
However, we believe that any potential negative effects are outweighed by the benefits of the Reverse Stock Split.
Effect on Shares of Common Stock
For the purposes of providing examples of the effect of the Reverse Stock Split on our Common Stock, the following table contains approximate information, based on share information as of the Record Date, of the effect of a Reverse Stock Split at certain ratios within the range of the proposed Reverse Stock Split ratios on the number of shares of our Common Stock authorized, outstanding, reserved for future issuance and not outstanding or reserved:
Status
Number of
Shares of
Common Stock
Authorized
Number of Shares of
Common Stock
Issued and
Outstanding
Number of Shares of
Common Stock
Underlying
Outstanding Options,
Warrants and
Convertible Notes
Number of Shares of
Common Stock Authorized
but Not Outstanding or
Reserved
Pre-Reverse Stock Split
800,000,000
548,737,651
1,500,350,746
Post-Reverse Stock Split 1:50
800,000,000
10,974,753
30,007,015
819,032,262
Post-Reverse Stock Split 1:55
800,000,000
9,977,048
27,279,104
762,743,848
Post-Reverse Stock Split 1:60
800,000,000
9,145,628
25,005,846
765,848,526
Post-Reverse Stock Split 1:65
800,000,000
8,442,118
23,082,319
768,475,563
Post-Reverse Stock Split 1:70
800,000,000
7,839,109
21,433,582
770,727,309
Post-Reverse Stock Split 1:75
800,000,000
7,316,502
20,004,677
772,678,821
Post-Reverse Stock Split 1:80
800,000,000
6,859,221
18,754,384
774,386,395
Post-Reverse Stock Split 1:85
800,000,000
6,455,737
17,651,185
775,893,078
Post-Reverse Stock Split 1:90
800,000,000
6,097,085
16,670,564
777,232,351
Post-Reverse Stock Split 1:95
800,000,000
5,776,186
15,793,166
778,430,648
Post-Reverse Stock Split 1:100
800,000,000
5,487,377
15,003,507
779,509,116
After the Effective Time of the Reverse Stock Split that our Board elects to implement, our Common Stock would have a new CUSIP number.
Effect on our Authorized Preferred Stock
The Reverse Stock Split, if implemented, would not affect the total authorized number of shares of our preferred stock or the par value of our preferred stock.
Effect on Outstanding Equity Awards, Warrants, and Equity Plans
If the Reverse Stock Split is approved by our stockholders and our Board decides to implement the Reverse Stock Split, as wasof the case immediately precedingEffective Time, based on the Reverse Stock Split. TheSplit ratio selected by the Board, proportionate adjustments will be made to all then-outstanding equity awards, Common Stock warrants and convertible debt with respect to the number of shares deliverable upon settlementof Common Stock subject to such award, warrant or vestingconvertible debt and the exercise or conversion price thereof. In addition, the number of restricted stock awardsshares of Common Stock available for issuance under the Stock Incentive Plan will be similarlyproportionately adjusted for the Reverse Stock Split ratio selected by the Board, such that fewer shares will be subject to our treatment of fractional shares.such plan.
Accounting MattersReduction in Stated Capital
The proposed amendmentPursuant to the Company's Articles of Incorporation will not affectReverse Stock Split, the par value of our common stock, which willCommon Stock would remain $0.001 par value per share. As a result as of the Reverse Stock Split, at the Effective Time, the stated capital on our balance sheet attributable to common stockour Common Stock would be reduced in proportion to the size of the Reverse Stock Split, subject to a minor adjustment in respect of the treatment of fractional shares, and the additional paid-in capital account onwould be credited with the amount by which the stated capital is reduced. Our stockholders’ equity, in the aggregate, would remain unchanged.
7

Beneficial Holders of Common Stock (i.e., stockholders who hold in street name)
Upon the implementation of the Reverse Stock Split, we intend to treat shares held by stockholders through a bank, broker, custodian or other nominee in the same manner as registered stockholders whose shares are registered in their names. Banks, brokers, custodians or other nominees will be instructed to effect the Reverse Stock Split for their beneficial holders holding our balance sheet will not change due toCommon Stock in street name. However, these banks, brokers, custodians or other nominees may have different procedures than registered stockholders for processing the Reverse Stock Split. Reported per share net incomeStockholders who hold shares of our Common Stock with a bank, broker, custodian or lossother nominee and who have any questions in this regard are encouraged to contact their banks, brokers, custodians or other nominees.
Registered “Book-Entry” Holders of Common Stock (i.e., stockholders that are registered on the transfer agent’s books and records but do not hold stock certificates)
Certain of our registered holders of Common Stock may hold some or all of their shares electronically in book-entry form with the transfer agent. These stockholders do not have stock certificates evidencing their ownership of the Common Stock. They are, however, provided with a statement reflecting the number of shares registered in their accounts.
Stockholders who hold shares electronically in book-entry form with the transfer agent will not need to take action (the exchange will be higher because thereautomatic) to receive whole shares of post-Reverse Stock Split Common Stock, subject to adjustment for treatment of fractional shares.
Holders of Certificated Shares of Common Stock
Stockholders holding shares of our Common Stock in certificated form will be fewersent a transmittal letter by our transfer agent after the Effective Time. The letter of transmittal will contain instructions on how a stockholder should surrender his, her or its certificate(s) representing shares of commonour Common Stock (the “Old Certificates”) to the transfer agent in exchange for certificates representing the appropriate number of whole shares of post-Reverse Stock Split Common Stock (the “New Certificates”). No New Certificates will be issued to a stockholder until such stockholder has surrendered all Old Certificates, together with a properly completed and executed letter of transmittal, to the transfer agent. No stockholder will be required to pay a transfer or other fee to exchange his, her or its Old Certificates. Stockholders will then receive a New Certificate(s) representing the number of whole shares of Common Stock to which they are entitled as a result of the Reverse Stock Split, subject to the treatment of fractional shares described below. Until surrendered, we will deem outstanding Old Certificates held by stockholders to be cancelled and only to represent the number of whole shares of post-Reverse Stock Split Common Stock to which these stockholders are entitled, subject to the treatment of fractional shares. Any Old Certificates submitted for exchange, whether because of a sale, transfer or other disposition of stock, outstanding.will automatically be exchanged for New Certificates. If an Old Certificate has a restrictive legend on the back of the Old Certificate, the New Certificate will be issued with the same restrictive legends that are on the back of the Old Certificate.
WE MAY ISSUE THE ADDITIONAL SHARES OF AUTHORIZED COMMON STOCK THAT WILL BECOME AVAILABLE AS A RESULT OF THE REVERSE STOCK SPLIT WITHOUT THE ADDITIONAL APPROVAL OF OUR STOCKHOLDERS.
Not a Going Private Transaction
Notwithstanding the decrease in the number of outstanding shares following the implementation of the Reverse Stock Split, the Board does not intend for this transaction to be the first step in a “going private transaction” within the meaning of Rule 13e-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the implementation of the proposed Reverse Stock Split will not cause the Company to go private.
No Appraisal Rights
Under the Nevada Revised Statutes, our stockholders are not entitled to appraisal rights with respect to the Reverse Stock Split, and we will not independently provide our stockholders with any such rights.
CertainMaterial U.S. Federal Income Tax Consequences of the Reverse Stock Split
The following discussion is a summary describes certainof material U.S. federal income tax consequences of thean implemented Reverse Stock Split to holdersU.S. Holders (as defined below). This summary is based upon the Internal Revenue Code of our common stock:1986, as amended (the “Code”), Treasury regulations promulgated thereunder, published rulings and administrative
Unless otherwise specifically indicated herein, this summary addresses
8

pronouncements of the Internal Revenue Service (“IRS”), and judicial decisions in each case in existence on the date hereof, all of which are subject to change. Any such change could apply retroactively and could adversely affect the tax consequences only todescribed below. No assurance can be given that the IRS will agree with the consequences described in this summary, or that a court will not sustain any challenge by the IRS in the event of litigation. No advance tax ruling has been or will be sought or obtained from the IRS regarding the tax consequences of the transactions described herein.
For purposes of this summary, a “U.S. Holder” is a beneficial owner of shares of our common stockCommon Stock that is (a) an individual who is a citizen or individual resident of the United States or who is resident in the United States for U.S. federal income tax purposes, (b) an entity that is classified for U.S. federal income tax purposes as a corporation and that is organized in or under the laws of the United States, or any state thereof, or the District of Columbia, or is otherwise subject totreated for U.S. federal income taxation on a net income basis in respect of our common stock (a “U.S. holder”). A trust may also be a U.S. holder if (1) a U.S. court is able to exercise primary supervision over administration of such trust and one or more U.S. persons have the authority to control all substantial decisions of the trust or (2) it has a valid election in place to be treatedtax purposes as a U.S. person. Andomestic corporation, (c) an estate whosethe income of which is subject to U.S. federal income taxation regardless of its source, may alsoor (d) a trust (i) whose administration is subject to the primary supervision of a court within the United States and all substantial decisions of which are subject to the control of one or more United States persons as described in Section 7701(a)(30) of the Code (“United States persons”), or (ii) that has a valid election in effect under applicable Treasury regulations to be treated as a U.S. holder. United States person.
This summary does not addressdiscuss all of theU.S. federal income tax consequencesconsiderations that may be relevant to anyU.S. Holders in light of their particular investor, including tax considerationscircumstances or that arise from rules of general application to all
10

TABLE OF CONTENTS

taxpayers ormay be relevant to certain classes of taxpayers or that are generally assumed to be known by investors. This summary also does not address the tax consequences to (i) personsbeneficial owners that may be subject to special treatment under U.S. federal income tax law such as banks,(for example, tax-exempt organizations, S corporations, partnership and other pass through entities (and investors therein), mutual funds, insurance companies, thriftbanks and other financial institutions, regulated investment companies,dealers in securities, brokers or traders in securities, commodities or currencies, that elect to use a mark-to-market method of accounting, real estate investment trusts, tax-exempt organizations, U.S. expatriates,regulated investment companies, individual retirement accounts, qualified pension plans, persons subject to the alternative minimum tax, traders in securities that elect to mark to market and dealers in securities or currencies, (ii) persons thatwho hold shares of our common stockCommon Stock as part of a position in a “straddle” or as part of a “hedging,” “conversion”straddle, hedging, constructive sale, conversion, or other integrated transaction, U.S. Holders that have a functional currency other than the U.S. dollar, and persons who acquired shares of our Common Stock as a result of the exercise of employee stock options or otherwise as compensation or through a tax-qualified retirement plan). Furthermore, this summary does not discuss any alternative minimum tax consequences or the Medicare contribution tax on net investment transaction for federal income tax purposes,and does not address any aspects of U.S. state or (iii) personslocal or non-U.S. taxation. This summary only applies to those beneficial owners that do not hold shares of our common stockCommon Stock as “capital assets” within the meaning of Section 1221 of the Code (generally, property held for investment).
If a partnership (or otheran entity classified as a partnership for U.S. federal income tax purposes) is the beneficial ownerpurposes as a partnership owns shares of our common stock,Common Stock, the U.S. federal income tax treatment of a partner inmember of the partnershipentity will generally depend on the status of the partnermember and the activities of the partnership. Partnershipsentity and such member. The tax treatment of such an entity, and the tax treatment of any member of such an entity, are not addressed in this summary. Any entity that hold our common stock, and partners in such partnerships, should consult their own tax advisors regarding theis classified for U.S. federal income tax consequencespurposes as a partnership and that owns shares of the Reverseour Common Stock, Split.and any members of such an entity, are encouraged to consult their tax advisors.
This summary is based on the provisions of the Internal Revenue Code of 1986, as amended, U.S. Treasury regulations, administrative rulings and judicial authority, all as in effect as of the date of this proxy statement. Subsequent developments in U.S. federal income tax law, including changes in law or differing interpretations, which may be applied retroactively, could have a material effect on the U.S. federal income tax consequences of the Reverse Stock Split.
PLEASE CONSULT YOURBENEFICIAL OWNERS OF SHARES OF OUR COMMON STOCK ARE ENCOURAGED TO SEEK ADVICE FROM THEIR OWN TAX ADVISORADVISORS REGARDING THE U.S. FEDERAL, STATE, LOCAL, AND FOREIGN INCOME AND OTHER TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT, IN YOURTAKING INTO ACCOUNT THEIR PARTICULAR CIRCUMSTANCESSITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT ARISING UNDER THE INTERNAL REVENUE CODE ANDU.S. FEDERAL INCOME, ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY OTHERSTATE, LOCAL OR NON-U.S. TAXING JURISDICTION.JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.
U.S. Holders
TheWe intend to take the position that the Reverse Stock Split should be treated asconstitutes a recapitalization for U.S. federal income tax purposes. Therefore,purposes pursuant to Section 368(a)(1)(E) of the Code. Assuming the Reverse Stock Split qualifies as a stockholder generallyrecapitalization:
a U.S. Holder will not recognize gain or loss on the Reverse Stock Split, except to Split;
the extent of cash, if any, received in lieu of a fractional share interest in the post-Reverse Stock Split shares. The aggregate tax basis of the post-split shares of our Common Stock received by a U.S. Holder in the Reverse Stock Split will be equal to the aggregate tax basis of the pre-split shares exchanged therefore (excluding any portion of the holder's basis allocated to fractional shares),therefor; and
the holding period of the post-split shares of our Common Stock received by a U.S. Holder in the Reverse Stock Split will include the holding period of the pre-split shares exchanged. A holderexchanged therefor.
9

U.S. Treasury regulations provide detailed rules for allocating the tax basis and holding period among shares of common stock which were acquired by a stockholder on different dates and at different prices. U.S. Holders that acquired shares of our Common Stock on different dates or at different prices should consult their tax advisors regarding the pre-split shares who receives cash will generally recognize gain or loss equal to the difference between the portionallocation of the tax basis of the pre-split shares allocated to the fractional share interest and the cash received. Such gain or loss will be a capital gain or loss and will be short term if the pre-split shares were held for one year or less and long term if held more than one year. No gain or loss will be recognized by us as a result of the Reverse Stock Split.holding period among such shares.
Interests of Directors and Executive Officers
Our directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this Reverse Split Proposal except to the extent of their ownership of shares of our Common Stock.
Required Vote Required
The affirmative voteconsent of the holders of a majority of the shares of common stockCommon Stock outstanding as of the Record Date is needed to approve the Reverse Stock Split.
THE BOARD UNANIMOUSLY RECOMMENDS A VOTETHAT YOU SUBMIT YOUR WRITTEN CONSENT “FOR” PROPOSAL 2, THE1, APPROVAL OF AN AMENDMENT TO OUR ARTICLES OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT, AT THE BOARD’S DISCRETION.
10

PROPOSAL 2

APPROVAL OF AN AMENDMENT TO OUR ARTICLES OF INCORPORATION TO INCREASE THE COMPANY’S OUTSTANDINGNUMBER OF AUTHORIZED SHARES OF COMMON STOCK.STOCK
The Board has approved an amendment to our Articles of Incorporation to increase the number of authorized shares of Common Stock to 2,500,000,000 shares from 800,000,000 shares. If approved, the amendment would amend and restate the text of the third paragraph thereof referring to the number of shares with par value in its entirety to read as follows:
“The total number of shares which the Corporation is authorized to issue is 2,505,000,000 shares. 2,500,000,000 shares will be Common Stock, each having a par value of $0.001. 5,000,000 shares shall be Preferred Stock, each having a par value of $0.001.”
On the Record Date, we had 548,737,651 shares of Common Stock issued and outstanding and 251,262,349 shares of Common Stock that were authorized but unissued. Also on the Record Date, we had (i) 1,006,490,519 shares of Common Stock potentially issuable upon exercise of outstanding warrants, (ii) 21,246,085 shares of Common Stock potentially issuable upon exercise of outstanding stock options and (iii) 472,614,142 shares of Common Stock potentially issuable upon the conversion of outstanding convertible notes. Accordingly, we need to increase our authorized shares of Common Stock in order to permit the exercise or conversion of all such exercisable or convertible securities. The Notes and the Warrants are not currently convertible into, or exercisable for, shares of our Common Stock. The Notes will be convertible and the Warrants exercisable at such time as our authorized and unissued shares of Common Stock are at a number sufficient to permit the exercise or conversion of all outstanding securities exercisable for, or convertible into, Common Stock.
The Board also believes that the availability of additional authorized shares of Common Stock will provide the Company with flexibility to issue Common Stock for a variety of general corporate purposes as the Board may determine to be desirable including, without limitation, stock splits (including splits effected through the declaration of stock dividends), raising capital, future financings, investment opportunities, licensing agreements, acquisitions or other distributions. The Company currently does not have any definitive plans, arrangements or understandings with respect to the issuance of the additional shares of Common Stock authorized by the proposed amendment to the Articles of Incorporation.
The proposed amendment to increase the number of authorized shares of Common Stock could, under certain circumstances, have an anti-takeover effect or delay or prevent a change in control of the Company by providing the Company the capability to engage in actions that would be dilutive to a potential acquiror, to pursue alternative transactions, or to otherwise increase the potential cost to acquire control of the Company. Thus, while we currently have no intent to employ the additional unissued authorized shares as an anti-takeover device, the proposed amendment may have the effect of discouraging future unsolicited takeover attempts. The Board is not aware of any such attempt to take control of the Company and would act in the best interest of stockholders if any attempt was made.
The proposed increase in the number of authorized shares of Common Stock will not change the number of shares of Common Stock outstanding, nor will it have any immediate dilutive effect or change the rights of current holders of the Company’s Common Stock, except that the Notes will be convertible into, and the Warrants exercisable for, our Common Stock at such time as our authorized and unissued shares of Common Stock are at a number sufficient to permit the exercise or conversion of all outstanding securities exercisable for, or convertible into, Common Stock. However, the issuance of additional shares of Common Stock authorized by this amendment to the Articles of Incorporation may occur at times or under circumstances as to have a dilutive effect on earnings per share, book value per share or the percentage voting or ownership interest of the present holders of our Common Stock.
Once the proposed amendment is approved, no further action by the stockholders would be necessary prior to the issuance of additional shares of Common Stock unless required by law or the rules of any stock exchange or national securities association on which the Common Stock is then listed or quoted. Under the proposed amendment, each of the newly authorized shares of Common Stock will have the same rights and privileges as currently authorized Common Stock. Adoption of the proposed amendment will not affect the rights of the holders of currently outstanding Common Stock, nor will it change the par value of the Common Stock, which will remain $0.001 par value per share. If the proposed amendment is adopted, it will become effective upon filing of a Certificate of Amendment to our Articles of Incorporation with the Nevada Secretary of State.
11

TABLE


SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information, as of November 30, 2020,the Record Date, with respect to the beneficial ownership of the Company’sour outstanding common stockCommon Stock by (i) any holder of more than five percent, (ii) each of the Company’sour named executive officers and directors, and (iii) the Company’sour directors and executive officers as a group.
Name of Beneficial Owner(1)
Number of
Shares
Percent of
Beneficially
Owned
Shares
Outstanding(2)
A. Michael Stolarski(3)
18,081,290
3.9%
Kevin A. Richardson II(4)
13,545,993
2.9%
Peter Stegagno(5)
3,968,007
0.9%
Iulian Cioanta(6)
3,186,146
0.7%
Lisa E. Sundstrom(7)
2,914,500
0.6%
John F. Nemelka(8)
1,446,055
0.3%
Alan Rubino(9)
1,419,800
0.3%
Maj-Britt Kaltoft(10)
700,000
0.2%
Thomas Price(11)
200,000
0.0%
All directors and executive officers as a group (9 persons)
45,461,791
9.7%
Opaleye, L.P.
31,428,554
6.7%
Manchester Explorer, L.P.
24,642,840
5.3%
Name of Beneficial Owner(1)
Number of Shares
Beneficially Owned
Percent of Shares
Outstanding(2)
Kevin A. Richardson, II(3)
16,795,993
3.0%
Peter Stegagno(4)
4,418,007
*
Lisa E. Sundstrom(5)
3,364,500
*
Morgan C. Frank(6)
38,085,646
6.9%
A. Michael Stolarski(7)
18,331,290
3.3%
James Tyler
1,250,000
*
Ian Miller(8)
7,780,825
1.4%
Jeffrey Blizard
—%
All directors and executive officers as a group (11 persons)
93,197,002
16.4%
Opaleye Management Inc.(9)
31,428,571
5.7%
Manchester Management PR, LLC(6)
Manchester Management Company, LLC
Manchester Explorer, L.P.
James E. Besser
41,335,646
7.5%
*
Denotes less than 1% of beneficial ownership.
(1)
Unless otherwise noted, each beneficial owner has the same address as the Company.us.
(2)
Applicable percentage ownership is based on 467,194,621548,737,651 shares of common stockCommon Stock outstanding as of November 30, 2020.the Record Date. “Beneficial ownership” includes shares for which an individual, directly or indirectly, has or shares voting or investment power, or both, and also includes options and warrants that are exercisable within 60 days of November 30, 2020.the Record Date. Unless otherwise indicated, all of the listed persons have sole voting and investment power over the shares listed opposite their names. Beneficial ownership as reported in the above table has been determined in accordance with Rule 13d-3 of the Exchange Act.
(3)
Includes options to purchase up to 1,069,8007,459,300 shares of common stock.
(4)
Includes options to purchase up to 4,209,300 shares of common stock.Common Stock. In addition, this amount includes 1,324,723 shares of common stockCommon Stock owned directly by Prides Capital Fund I, L.P. Prides Capital Partners LLC is the general partner of Prides Capital Fund I, L.P. and Mr. Richardson is the controlling shareholder of Prides Capital Partners LLC; therefore, under certain provisions of the Exchange Act, he may be deemed to be the beneficial owner of such securities. Mr. Richardson has also been deputized by Prides Capital Partners LLC to serve on theour Board. Mr. Richardson disclaims beneficial ownership of all such securities except to the extent of any indirect pecuniary interest (within the meaning of Rule 16a-1 of the Exchange Act) therein.
(4)
Includes options to purchase up to 3,658,144 shares of Common Stock.
(5)
Consists of options to purchase up to 3,208,1443,364,500 shares of common stock.Common Stock.
(6)
Manchester Management PR, LLC (“Manchester”) and Manchester Management Company, LLC (“GP”) may be deemed to be the owner of 39,085,646 shares of Common Stock. Manchester and GP have the sole power to vote or direct the vote of 0 shares of Common Stock, have the shared power to vote or direct the vote of 39,085,646 shares of Common Stock, have the sole power to dispose or direct the disposition of 0 shares of Common Stock, and have the shared power to dispose or direct the disposition of 39,085,646 shares of Common Stock.
Manchester Explorer, L.P. (“Explorer”) may be deemed to be the beneficial owner of 36,585,646 shares of Common Stock. Explorer has the sole power to vote or direct the vote of 0 shares of Common Stock, has the shared power to vote or direct the vote of 36,585,646 shares of Common Stock, has the sole power to dispose or direct the disposition of 0 shares of Common Stock, and has the shared power to dispose or direct the disposition of 36,585,646 shares of Common Stock.
Mr. Besser has the sole power to vote or direct the vote of 2,500,000 shares of Common Stock, has the shared power to vote or direct the vote of 39,085,646 shares of Common Stock, has the sole power to dispose or direct the disposition of 2,500,000 shares of Common Stock, and has the shared power to dispose or direct the disposition of 39,085,646 shares of Common Stock.
Mr. Frank has the sole power to vote or direct the vote of 1,500,000 shares of Common Stock, has the shared power to vote or direct the vote of 36,585,646 shares of Common Stock, has the sole power to dispose or direct the disposition of 1,500,000 shares of Common Stock, and has the shared power to dispose or direct the disposition of 36,585,646 shares of Common Stock.
Mr. Besser is the managing member of Manchester and GP and Mr. Frank serves as a portfolio manager and as a consultant for Explorer. Manchester is the investment manager to Explorer and GP is the general partner of Explorer. The principal business address for each of Manchester, GP, Explorer and Messrs. Besser and Frank is 2 Calle Candina, #1701, San Juan, Puerto Rico, 00907.
(7)
Includes options to purchase up to 3,050,0001,319,800 shares of common stock.
(7)
Consists of options to purchase up to 3,170,741 shares of common stock.Common Stock.
(8)
Consists of options to purchase up to 2,914,500 shares of common stock.
(9)
Includes options to purchase up to 1,434,8001,000,000 shares of common stock.
(10)
Includes optionsCommon Stock and warrants to purchase up to 1,419,800125,000 shares of common stock.Common Stock.
(11)(9)
Includes options
Opaleye Management Inc. (the “Opaleye”) serves as investment manager to purchase upOpaleye, L.P. and as a portfolio manager for a separate managed account (the “Managed Account”), and may be deemed to 700,000indirectly beneficially own securities owned by the Managed Account. Opaleye disclaims beneficial ownership of the shares held by the Managed Account. Mr. James Silverman is the President of common stock.Opaleye. The address of Opaleye is One Boston Place, 26th Floor, Boston, MA 02108.
1213

TABLE OF CONTENTS

ADDITIONAL INFORMATION
Stockholder Proposals for the 2021Next Annual Meeting
Requirements for Stockholder Proposals to Be Considered for Inclusion in Our Proxy Materials. To be considered for inclusion in next year’sthe proxy materials for our 2021next annual meeting of stockholders, your proposal must be submitted in writing by March 4, 2021 to the Company’s Secretary at 3360 Martin Farm Road, Suite 100, Suwanee, Georgia 30024 and comply with the requirements in the Company’s Bylaws and all applicable requirements of Rule 14a-8 promulgated under the Securities Exchange Act of 1934, as amended, provided, however, that if our 2021 annual meeting of stockholders is held before June 23, 2021 or after August 22, 2021, then the deadline is a reasonable amount of time prior to the date we begin to print and distribute our proxy statement for the 2021such annual meeting of stockholders.stockholders to the Company’s Secretary at 11495 Valley View Road, Eden Prairie, Minnesota 55344, and comply with the requirements in our Bylaws and all applicable requirements of Rule 14a-8 promulgated under the Exchange Act.
Requirements for Stockholder Proposals to be Brought Before an Annual Meeting. If you wish to submit a proposal that is to be included in next year’sthe proxy materials for our next annual meeting of stockholders, you must do so not less than 50 days nor more than 75 days prior to the meeting; provided, however, that in the event less than 60 days’ notice or prior public disclosure of the date of the meeting is given or made to stockholders, notice by the stockholder to be timely must be so received not later than the close of business on the tenth day following the day on which such notice of the date of the meeting was mailed or such public disclosure was made. You are also advised to review our Bylaws, which contain additional requirements regarding submission of stockholder proposals.
Householding of Proxy Materials
The SEC adopted rules that permit us to send a single special report and proxy statementsConsent Solicitation Statement to any household at which two or more stockholders reside unless we have received contrary instructions from one of the stockholders. Each stockholder will continue to receive a separate proxywritten consent card. Upon written or oral request to our Corporate Secretary, at 3360 Martin Farm11495 Valley View Road, Suite 100, Suwanee, Georgia 30024Eden Prairie, Minnesota 55344 or by phone at (770) 419-7525, we will deliver a separate copy of the special report or proxy statement, as applicable,Consent Solicitation Statement to you at the shared address within 30 days of your request. Any stockholders who share the same address and currently receive multiple copies of our consent solicitation materials or proxy materials who wish to receive only one copy in the future can contact the Corporate Secretary regarding such request at the address and phone number listed above.
A number of brokerage firms have already instituted householding. If your household has multiple accounts of our stock, you may have received a householding notification from your broker. Please contact your broker directly if you have questions, require additional copies of the proxy statement or special report,Consent Solicitation Statement or wish to revoke your decision to household, and thereby receive multiple reports.
Other Matters
We currently know of no other matters to be voted on at the 2020 Special Meeting. If any other matters properly come before the meeting, the persons named in the form of proxy intend to vote the shares they represent as the board of directors may recommend. Discretionary authority with respect to such other matters is granted by execution of the proxy.
A copy of the Company’s annual, quarterly and current reports, proxy statements and other information, including our financial information, are available without charge upon written request to: Corporate Secretary, SANUWAVE Health, Inc., 3360 Martin Farm Road, Suite 100, Suwanee, Georgia 30024.
1314

TABLE OF CONTENTS

APPENDIX A
CERTIFICATE OF INCORPORATION
OF
SANUWAVE HEALTH, INC.
ARTICLE I
NAME OF THE CORPORATION
The name of the corporation is SANUWAVE Health, Inc. (the “Corporation”).
ARTICLE II
REGISTERED AGENT
The address of the registered office of the Corporation in the State of Delaware is 1209 Orange Street, in the City of Wilmington, 19801, County of New Castle. The name of the registered agent of the Corporation at such address is The Corporation Trust Company.
ARTICLE III
BUSINESS PURPOSE
The nature of the business or purposes to be conducted or promoted by the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware (the “DGCL”).
ARTICLE IV
CAPITAL STOCK
Section 4.01 Authorized Classes of Stock. The total number of shares of stock of all classes of capital stock that the Corporation is authorized to issue is 805,000,000, of which 800,000,000 shares shall be shares of common stock having a par value of $0.001 per share (“Common Stock”) and 5,000,000 shares shall be shares of preferred stock having a par value of $0.001 per share (“Preferred Stock”).
Section 4.02 Common Stock. Except as otherwise required by law, as provided in this Certificate of Incorporation, and as otherwise provided in the resolution or resolutions, if any, adopted by the board of directors of the Corporation (the “Board of Directors”) with respect to any series of the Preferred Stock, the holders of the Common Stock shall exclusively possess all voting power. Each holder of shares of Common Stock shall be entitled to one vote for each share held by him. Subject to the rights of holders of any series of outstanding Preferred Stock, holders of shares of Common Stock shall have equal rights of participation in the dividends and other distributions in cash, stock, or property of the Corporation when, as and if declared thereon by the Board of Directors from time to time out of assets or funds of the Corporation legally available therefor and shall have equal rights to receive the assets and funds of the Corporation available for distribution to stockholders in the event of any liquidation, dissolution, or winding up of the affairs of the Corporation, whether voluntary or involuntary.
Section 4.03 Preferred Stock. The Board of Directors is hereby authorized to provide, out of the unissued shares of Preferred Stock, for one or more series of Preferred Stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional, or other special rights, if any, and any qualifications, limitations, or restrictions thereof, of the shares of such series, as shall be stated in the resolution or resolutions providing for the issuance of such series adopted by the Board of Directors. The authority of the Board with respect to each series of Preferred Stock shall include, but not be limited to, determination of the following:
(a)
the designation of the series;
(b)
the number of shares of the series;
(c)
the dividend rate or rates on the shares of that series, whether dividends will be cumulative, and if so, from which date or dates, and the relative rights of priority, if any, of payment of dividends on shares of that series;
(d)
whether the series will have voting rights in addition to the voting rights provided by law, and, if so, the terms of such voting rights;
A-1

TABLE OF CONTENTS

(e)
whether the series will have conversion privileges, and, if so, the terms and conditions of such conversion, including provision for adjustment of the conversion rate in such events as the Board of Directors shall determine;
(f)
whether or not the shares of that series shall be redeemable, in whole or in part, at the option of the Corporation or the holder thereof, and if made subject to such redemption, the terms and conditions of such redemption, including the date or dates upon or after which they shall be redeemable, and the amount per share payable in case of redemptions, which amount may vary under different conditions and at different redemption rates;
(g)
the terms and amount of any sinking fund provided for the purchase or redemption of the shares of such series;
(h)
the rights of the shares of that series in the event of voluntary or involuntary liquidation, dissolution, or winding up of the Corporation, and the relative rights of priority, if any, of payment of shares of that series;
(i)
the restrictions, if any, on the issue or reissue of any additional Preferred Stock; and
(j)
any other relative rights, preferences, and limitations of that series.
ARTICLE V
BOARD OF DIRECTORS
Section 5.01 General Powers. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors.
Section 5.02 Number. Subject to any rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, the number of directors of the Corporation which shall constitute the entire Board of Directors shall be filed as set out in the by-laws of the Corporation (the “By-Laws”).
Section 5.03 Written Ballot. Unless and except to the extent that the By-Laws shall so require, the election of directors of the Corporation need not be by written ballot.
ARTICLE VI
LIMITATION OF LIABILITY; INDEMNIFICATION
Section 6.01 Limitation of Liability. To the fullest extent permitted by the DGCL as it presently exists or may hereafter be amended, a director of the Corporation shall not be personally liable to the Corporation or to its stockholders for monetary damages for any breach of fiduciary duty as a director. No amendment to, modification of, or repeal of this Section 6.01 shall apply to or have any effect on the liability or alleged liability of any director of the Corporation for or with respect to any acts or omissions of such director occurring prior to such amendment.
Section 6.02 Indemnification. The corporation shall indemnify to the fullest extent permitted by law as it presently exists or may hereafter be amended any person made or threatened to be made a party to an action or proceeding, whether criminal, civil, administrative, or investigative, by reason of the fact that he, his testator, or intestate is or was a director or officer of the Corporation or any predecessor of the Corporation, or serves or served at any other enterprise as a director or officer at the request of the Corporation or any predecessor to the Corporation. Any amendment, repeal, or modification of this Section 6.02 shall not adversely affect any right or protection hereunder of any person in respect of any act or omission occurring prior to the time of such repeal or modification.
ARTICLE VII
BY-LAWS
Section 7.01 Board of Directors. In furtherance and not in limitation of the powers conferred by law, the Board of Directors is expressly authorized and empowered to adopt, amend, alter, or repeal the By-Laws without any action on the part of the stockholders.
Section 7.02 Stockholders. The stockholders shall also have the power to adopt, amend, alter, or repeal the By-Laws; provided that, in addition to any affirmative vote of the holders of any particular class or series of capital stock of the Corporation required by applicable law or this Certificate of Incorporation, such adoption, amendment, alteration, or repeal shall be approved by the affirmative vote of the holders of at least 66 2/3% of the voting power of the shares of the then outstanding voting stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class.
A-2

TABLE OF CONTENTS

ARTICLE VIII
AMENDMENTS
The Corporation reserves the right to amend, alter, or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by the laws of the State of Delaware, and all rights conferred herein are granted subject to this reservation; provided however, that notwithstanding any other provision of this Certificate of Incorporation or applicable law that might permit a lesser vote or no vote and in addition to any affirmative vote of the holders of any particular class or series of capital stock of the Corporation required by applicable law or this Certificate of Incorporation, the affirmative vote of the holders of at least 66 2/3% of the voting power of the shares of the then outstanding voting stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required to amend, alter, repeal, or adopt any provisions inconsistent with this Article VIII.
ARTICLE IX
FORUM SELECTION
Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall, to the fullest extent permitted by law, be the sole and exclusive forum for: (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim for breach of a fiduciary duty owed by any director, officer, employee or agent of the Corporation to the Corporation or the Corporation's stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL, the Certificate of Incorporation or the By-laws or (iv) any action asserting a claim governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein
ARTICLE X
The name and mailing address of the incorporator of the Corporation are as follows:
Kevin A. Richardson II
Chief Executive Officer
SANUWAVE Health, Inc.
3360 Martin Farm Road, Ste 100 Suwanee, GA 30024
* * * *
I, THE UNDERSIGNED, for the purpose of forming a corporation under the laws of the State of Delaware, do make, file and record this Certificate of Incorporation, and do certify that the facts herein stated are true, and I have accordingly hereunto set my hand this    day of     , 2020.
Kevin A. Richardson II, Incorporator
A-3

TABLE OF CONTENTS



TABLE OF CONTENTS